Parachlorophenol

Parachlorophenol

SCHEMBL8510047

COc1ccc([C@H]2c3[nH]c4ccc(Cl)cc4c3CCN2C(=O)O)cc1.Oc1ccc(Cl)cc1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.61
MAPT P10636 3/20 0.61
SMN1; SMN2 Q16637 2/20 0.60
ABCG2 Q9UNQ0 8/20 0.58
ABCB1 P08183 6/20 0.58
KIF11 P52732 6/20 0.55
HTR1A P08908 1/20 0.52
DRD4 P21917 1/20 0.52
HTR1D P28221 1/20 0.52
HTR1B P28222 1/20 0.52
HTR2A P28223 1/20 0.52
HTR2C P28335 1/20 0.52
HTR1E P28566 1/20 0.52
HTR7 P34969 1/20 0.52
DRD3 P35462 1/20 0.52
HTR2B P41595 1/20 0.52
HTR3A P46098 1/20 0.52
HTR5A P47898 1/20 0.52
HTR6 P50406 1/20 0.52
SIGMAR1 Q99720 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL904374 0.95 TP53 (0.66) TP53MAPTSMN1; SMN2ABCG2ABCB1
SCHEMBL20704712 0.95 TP53 (0.66) TP53MAPTSMN1; SMN2ABCG2ABCB1
SCHEMBL20704585 0.95 TP53 (0.66) TP53MAPTSMN1; SMN2ABCG2ABCB1
SCHEMBL11912892 0.90 TP53 (0.60) TP53MAPTSMN1; SMN2ABCG2ABCB1
SCHEMBL11912929 0.88 TP53 (0.64) TP53MAPTSMN1; SMN2ABCG2ABCB1
Emvododstat SCHEMBL8509210 0.87 TP53 (0.62) TP53MAPTSMN1; SMN2ABCG2ABCB1
SCHEMBL15087042 0.87 TP53 (0.62) TP53MAPTSMN1; SMN2ABCG2ABCB1
Emvododstat SCHEMBL764056 0.87 TP53 (0.62) TP53MAPTSMN1; SMN2ABCG2ABCB1
SCHEMBL16549468 0.87 ABCG2 (0.73) TP53MAPTSMN1; SMN2ABCG2ABCB1
Emvododstat SCHEMBL9962251 0.87 TP53 (0.62) TP53MAPTSMN1; SMN2ABCG2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120136154-A1 PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES PTC THERAPEUTICS, INC. 2012-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120136154-A1 PROCESSES FOR THE PREPARATION OF SUBSTITUTED TETRAHYDRO BETA-CARBOLINES TPH1, TPH2, HTR1B TP53 4290/4885MAPT 1428/4885SMN1; SMN2 1796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.